Scott C. Morgan

Scott C. Morgan

Université d'Ottawa - Ottawa / Canada
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 4962820
University of Ottawa
person_outline Scott C. Morgan's MOST POPULAR ARTICLES
1-) Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised …DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ...The Lancet Oncology 20 (11), 1531-1543, 20193652019
2-) Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline EndorsementRC Chen, RB Rumble, DA Loblaw, A Finelli, B Ehdaie, MR Cooperberg, ...Journal of Clinical Oncology 34 (18), 2182-2190, 20163602016
3-) External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative … TJ Whelan, JA Julian, TS Berrang, D Kim, I Germain, AM Nichol, M Akra, ... The Lancet 394 (10215), 2165-2172, 2019 2452019
4-) Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non …AC Tree, P Ostler, H van der Voet, W Chu, A Loblaw, D Ford, S Tolan, ...The Lancet Oncology 23 (10), 1308-1320, 20222082022
5-) Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guidelineSC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ...Practical radiation oncology 8 (6), 354-360, 20182072018